Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with Parkinson's disease that has no known cause (called idiopathic Parkinson's disease).
- People who are between 40 and 80 years old.
- People whose Parkinson's medications have remained unchanged for more than 3 months.
- People whose Parkinson's symptoms fall within a mild-to-moderate range on a standard rating scale called the Hoehn and Yahr scale (stages I to III) (confirm with trial site).
- People who are able to walk continuously for at least 10 minutes.
- People who are able to understand and follow spoken or written instructions.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have a neurological condition other than Parkinson's disease.
- People who have severe disorders affecting the muscles, bones, joints, heart, or lungs.
- People who score below 24 on a standard memory and thinking test called the MMSE (Mini-Mental State Examination).
- People who have a medical reason that makes a brain stimulation technique called TMS (transcranial magnetic stimulation) unsafe for them.
- People who have had, or are scheduled to have, brain or neurological surgery during the period of the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Corticospinal inhibition : Cortical silent period (CSP) (ms); Intracortical inhibition : Short-interval intracortical inhibition (SICI) (%); Mini-Balance Evaluation Systems Test (Mini-BESTest); Falls Efficacy Scale-International (FES-I)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.